Loading resources...
§ Grant
Grants for health researchers, startups, and non-profits, supporting transformative health innovations and breakthroughs.
The Advanced Research Projects Agency for Health is a federal grant and nondilutive program administered within the Department of Health and Human Services. Operating with an annual budget exceeding one and a half billion dollars, the agency distributes capital through Broad Agency Announcements and Innovative Solutions Openings. Individual awards range from several million to tens of millions of dollars for breakthrough medical platforms. Recent initiatives include a 100 million dollar Sprint for Women's Health and the Emerging Health Innovators program, featuring specific funding tracks for early career investigators and community health workers. Modeled after DARPA, the agency collaborates with the National Institutes of Health and maintains a nationwide innovation network involving University of Iowa, Rutgers Health, and Johns Hopkins. This resource targets startups, academics, and nonprofit organizations seeking capital to develop transformative biomedical technologies and scalable healthcare solutions.
ARPA-H (Advanced Research Projects Agency for Health) is a federal funding agency within the U.S. Department of Health and Human Services that supports high-risk, high-reward biomedical research. The agency provides awards from several million to tens of millions of dollars for transformative health technologies that could revolutionize disease prevention, diagnosis, and treatment.
Startups, academic researchers, and nonprofit organizations developing transformative biomedical technologies are eligible. ARPA-H specifically targets projects that are too risky for traditional NIH funding but have the potential for breakthrough impact on human health. The agency welcomes proposals from unconventional performers and cross-disciplinary teams.
Funded teams receive several million to tens of millions of dollars in non-dilutive support for research and development. ARPA-H assigns dedicated program managers who actively guide projects toward milestones and commercial viability. The agency also facilitates connections with FDA regulators, clinical partners, and investors to accelerate the path from discovery to patient impact.
ARPA-H releases funding opportunities through its website and the federal grants portal. Each announcement specifies technical focus areas, eligibility criteria, and submission timelines. The agency uses a streamlined review process designed to move faster than traditional NIH grant cycles, with an emphasis on bold ideas and capable teams.
Launched in 2022, ARPA-H has rapidly deployed funding across areas including cancer detection, pandemic preparedness, gene editing, and health equity. The agency's portfolio includes projects aimed at developing universal organ transplant solutions, next-generation surgical tools, and AI-powered diagnostic platforms.
ARPA-H is a federal agency within HHS that funds high-risk, high-reward biomedical research with transformative potential for human health.
Awards range from several million to tens of millions of dollars per project.
Startups, academic researchers, and nonprofits developing transformative biomedical technologies.
ARPA-H targets higher-risk, more transformative projects than traditional NIH grants, with active program management and faster review processes.
ARPA-H was launched in 2022 and has rapidly deployed funding across cancer, pandemic preparedness, gene editing, and health equity.